{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:42:09Z","timestamp":1781887329341,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Geneva, Switzerland"},{"name":"Ernst & Lucie Schmidheiny"},{"name":"Pierre Mercier"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejps.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T22:00:10Z","timestamp":1452549610000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["5-Benzylidene-hydantoin is a new scaffold for SIRT inhibition: From virtual screening to activity assays"],"prefix":"10.1016","volume":"85","author":[{"given":"Lionel","family":"Sacconnay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Ryckewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Marco","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Dos Santos","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Jachno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Michailovien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Zubrien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daumantas","family":"Matulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alain","family":"Carrupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Avello","family":"Sim\u00f5es-Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-5899","authenticated-orcid":false,"given":"Alessandra","family":"Nurisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.01.010_bb0005","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1021\/j100384a009","article-title":"Ion water interaction potentials derived from free-energy perturbation simulations","volume":"94","author":"Aqvist","year":"1990","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0010","series-title":"Solubility, Permeability, and Charge State","article-title":"Absorption and drug development","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.ejps.2016.01.010_bb0015","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0020","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1021\/bi049592e","article-title":"Substrate specificity and kinetic mechanism of the Sir2 family of NAD+ \u2212dependent histone\/protein deacetylases","volume":"43","author":"Borra","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2016.01.010_bb0025","series-title":"Amber 12","author":"Case","year":"2012"},{"key":"10.1016\/j.ejps.2016.01.010_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1535-7163.MCT-07-0477","article-title":"Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines","volume":"7","author":"Cavazzoni","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2016.01.010_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-1280(99)00360-7","article-title":"Molecular fields in quantitative structure permeation relationships: the VolSurf approach","volume":"503","author":"Cruciani","year":"2000","journal-title":"J. Mol. Struct. (THEOCHEM)"},{"key":"10.1016\/j.ejps.2016.01.010_bb0040","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1021\/jm500777s","article-title":"Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach","volume":"57","author":"Cui","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0045","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald \u2014 an N.Log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2016.01.010_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cmdc.201402431","article-title":"The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model","volume":"10","author":"Di Fruscia","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2016.01.010_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0060","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1021\/jm400204k","article-title":"Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3","volume":"56","author":"Disch","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/emmm.201302451","article-title":"SIRT1 and SIRT2: emerging targets in neurodegeneration","volume":"5","author":"Donmez","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejps.2016.01.010_bb0070","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1128\/MCB.23.9.3173-3185.2003","article-title":"Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle","volume":"23","author":"Dryden","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejps.2016.01.010_bb0075","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/bbrc.2000.3000","article-title":"Phylogenetic classification of prokaryotic and eukaryotic sir2-like proteins","volume":"273","author":"Frye","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2016.01.010_bb0080","doi-asserted-by":"crossref","first-page":"E2772","DOI":"10.1073\/pnas.1303628110","article-title":"Ex-527 inhibits sirtuins by exploiting their unique NAD + \u2212dependent deacetylation mechanism","volume":"110","author":"Gertz","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2016.01.010_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2014.12.028","article-title":"Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach","volume":"92","author":"Goracci","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0090","doi-asserted-by":"crossref","first-page":"e107729","DOI":"10.1371\/journal.pone.0107729","article-title":"Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies","volume":"9","author":"Guan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2016.01.010_bb0095","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1158\/0008-5472.CAN-05-3617","article-title":"Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes","volume":"15","author":"Heltweg","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2016.01.010_bb0100","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1074\/jbc.M113.487736","article-title":"A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer","volume":"289","author":"Hoffmann","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/jm901055u","article-title":"Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ dependent histone deacetylases (sirtuins)","volume":"53","author":"Huber","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0110","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1021\/jm800639h","article-title":"Oxadiazole-carbonylamino thioureas as SIRT1 and SIRT2 inhibitors","volume":"51","author":"Huhtiniemi","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0115","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbrc.2008.01.114","article-title":"SIRT2 interacts with 14-3-3 \u03b2\/\u03c8 and down-regulates the activity of p53","volume":"368","author":"Jin","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2016.01.010_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmet.2007.07.003","article-title":"SIRT2 regulates adipocyte differentiation through FoxO1 acetylation\/deacetylation","volume":"6","author":"Jing","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejps.2016.01.010_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","article-title":"Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation","volume":"245","author":"Jones","year":"1995","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejps.2016.01.010_bb0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejmech.2015.02.045","article-title":"Docking and binding free energy calculations of sirtuin inhibitors","volume":"93","author":"Karaman","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2011.09.004","article-title":"SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC\/C activity","volume":"20","author":"Kim","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2016.01.010_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2015.04.025","article-title":"Virtual screening approach of sirtuin inhibitors results in two new scaffolds","volume":"76","author":"Kokkonen","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.01.010_bb0145","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2016.01.010_bb0150","first-page":"82","article-title":"SIRT2 as a therapeutic target for age-related disorders","volume":"3","author":"Machado de Oliveira","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2016.01.010_bb0155","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm401411z","article-title":"Molecular similarity in medicinal chemistry","volume":"57","author":"Maggiora","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0160","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1021\/jm4018064","article-title":"Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors","volume":"57","author":"Mahajan","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0165","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/jm201243p","article-title":"Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry","volume":"55","author":"Mendgen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jsb.2013.02.012","article-title":"Crystal structure analysis of human SIRT2 and its ADP-ribose complex","volume":"182","author":"Moniot","year":"2013","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejps.2016.01.010_bb0175","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1021\/jm050522v","article-title":"Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1","volume":"48","author":"Napper","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0180","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/jm700972e","article-title":"Structure activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode","volume":"5","author":"Neugebauer","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD(+)-dependent tubulin deacetylase","volume":"11","author":"North","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejps.2016.01.010_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejps.2016.01.010_bb0195","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue \u03b1-synuclein-mediated toxicity in models of Parkinson's disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejps.2016.01.010_bb0200","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-09-0971","article-title":"SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2","volume":"9","author":"Peck","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2016.01.010_bb0205","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.ejps.2016.01.010_bb0210","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1242\/jcs.073783","article-title":"SIRT2 regulates NF-kappa B-dependent gene expression through deacetylation of p65 Lys310","volume":"123","author":"Rothgiesser","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejps.2016.01.010_bb0215","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1038\/ncomms7263","article-title":"Selective SIRT2 inhibition by ligand-induced rearrangement of the active site","volume":"6","author":"Rumpf","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2016.01.010_bb0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.ejps.2016.01.010_bb0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.toxlet.2014.07.002","article-title":"Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols","volume":"229","author":"Ryckewaert","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2016.01.010_bb0230","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/pro.5560040611","article-title":"On the role of Glu-68 in alcohol-dehydrogenase","volume":"4","author":"Ryde","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2016.01.010_bb0235","doi-asserted-by":"crossref","first-page":"e2689","DOI":"10.1371\/journal.pntd.0002689","article-title":"Computational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicals","volume":"8","author":"Sacconnay","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2016.01.010_bb0240","article-title":"Alkaloids from psychotria target sirtuins: in silico and in vitro interaction studies","volume":"1\u20138","author":"Sacconnay","year":"2015","journal-title":"Planta Med."},{"key":"10.1016\/j.ejps.2016.01.010_bb0245","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.74.082803.133500","article-title":"The biochemistry of sirtuins","volume":"75","author":"Sauve","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0250","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1021\/jm500930h","article-title":"Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells","volume":"57","author":"Seifert","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0255","doi-asserted-by":"crossref","first-page":"14178","DOI":"10.1073\/pnas.250422697","article-title":"Silent information regulator 2 family of NAD-dependent histone\/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose","volume":"97","author":"Tanner","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.01.010_bb0260","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.bmcl.2014.03.026","article-title":"Identification of novel SIRT2-selective inhibitors using a click chemistry approach","volume":"24","author":"Tatum","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2016.01.010_bb0265","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/cb100376q","article-title":"A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase","volume":"6","author":"Taylor","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2016.01.010_bb0270","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.bmcl.2015.04.068","article-title":"Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors","volume":"12","author":"Therrien","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2016.01.010_bb0275","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/cmdc.200800104","article-title":"Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testing","volume":"3","author":"Uciechowska","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2016.01.010_bb0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1039\/C1MD00214G","article-title":"Binding free energy calculations and biological testing of novel thiobarbiturates asinhibitors of the human NAD+ dependent histone deacetylase Sirt2","volume":"3","author":"Uciechowska","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejps.2016.01.010_bb0285","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1101\/gad.1412706","article-title":"SIRT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis","volume":"20","author":"Vaquero","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejps.2016.01.010_bb0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1474-9726.2007.00304.x","article-title":"SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction","volume":"6","author":"Wang","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejps.2016.01.010_bb0295","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejmech.2014.12.027","article-title":"Functionalized tetrahydro-1H-pyrido [4,3-b]indoles: a novel chemotype with sirtuin 2 inhibitory activity","volume":"92","author":"Yang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0305","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejmech.2014.06.060","article-title":"Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in-\u00e1vitro studies, molecular docking analysis and evaluation of their anti-cancer properties","volume":"83","author":"Yoon","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0310","first-page":"1399","article-title":"The emerging and diverse roles of sirtuins in cancer: a clinical perspective","volume":"6","author":"Yuan","year":"2013","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.ejps.2016.01.010_bb0315","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/jm301431y","article-title":"The 2.5A crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition","volume":"56","author":"Zhao","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2016.01.010_bb0320","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.ejmech.2009.01.035","article-title":"5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line","volume":"44","author":"Zuliani","year":"2009","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716300100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716300100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T03:23:24Z","timestamp":1537068204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716300100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":64,"alternative-id":["S0928098716300100"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.01.010","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Benzylidene-hydantoin is a new scaffold for SIRT inhibition: From virtual screening to activity assays","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}